Researchers develop new oral diarrhea vaccine
University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of diarrhea in children living in low and middle income countries result in 400 million diarrheal episodes and approximately 300 000 deaths among children per year. ETEC is also the leading cause of illness among international travelers to developing countries. Among the 65 million people travelling from industrialized countries to ETEC